Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.24% | 148.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.24% | 148.38% | |||
| Cost of Revenue | 0.24% | 199.50% | |||
| Gross Profit | 0.24% | 60.30% | |||
| SG&A Expenses | 0.24% | 16.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.26% | -4,928.26% | |||
| Total Operating Expenses | 0.24% | 100.88% | |||
| Operating Income | 0.27% | 108.88% | |||
| Income Before Tax | 0.22% | 111.38% | |||
| Income Tax Expenses | 0.24% | 16,570.00% | |||
| Earnings from Continuing Operations | -0.25% | 69.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.22% | -494.72% | |||
| Net Income | -0.23% | -21.43% | |||
| EBIT | 0.27% | 108.88% | |||
| EBITDA | 0.27% | 138.90% | |||
| EPS Basic | 0.00% | -20.00% | |||
| Normalized Basic EPS | 0.00% | -33.33% | |||
| EPS Diluted | 0.00% | -20.00% | |||
| Normalized Diluted EPS | 0.00% | -33.33% | |||
| Average Basic Shares Outstanding | 0.00% | 4.39% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||